1. Home
  2. PHUN vs DYAI Comparison

PHUN vs DYAI Comparison

Compare PHUN & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHUN
  • DYAI
  • Stock Information
  • Founded
  • PHUN 2009
  • DYAI 1979
  • Country
  • PHUN United States
  • DYAI United States
  • Employees
  • PHUN N/A
  • DYAI N/A
  • Industry
  • PHUN EDP Services
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PHUN Technology
  • DYAI Health Care
  • Exchange
  • PHUN Nasdaq
  • DYAI Nasdaq
  • Market Cap
  • PHUN 53.5M
  • DYAI 54.4M
  • IPO Year
  • PHUN N/A
  • DYAI 2004
  • Fundamental
  • Price
  • PHUN $2.92
  • DYAI $1.21
  • Analyst Decision
  • PHUN Buy
  • DYAI Strong Buy
  • Analyst Count
  • PHUN 2
  • DYAI 1
  • Target Price
  • PHUN $7.50
  • DYAI $6.00
  • AVG Volume (30 Days)
  • PHUN 236.6K
  • DYAI 25.3K
  • Earning Date
  • PHUN 05-08-2025
  • DYAI 05-13-2025
  • Dividend Yield
  • PHUN N/A
  • DYAI N/A
  • EPS Growth
  • PHUN N/A
  • DYAI N/A
  • EPS
  • PHUN N/A
  • DYAI N/A
  • Revenue
  • PHUN $3,189,000.00
  • DYAI $3,495,389.00
  • Revenue This Year
  • PHUN $70.87
  • DYAI $117.40
  • Revenue Next Year
  • PHUN N/A
  • DYAI N/A
  • P/E Ratio
  • PHUN N/A
  • DYAI N/A
  • Revenue Growth
  • PHUN N/A
  • DYAI 20.58
  • 52 Week Low
  • PHUN $2.22
  • DYAI $0.93
  • 52 Week High
  • PHUN $14.60
  • DYAI $2.67
  • Technical
  • Relative Strength Index (RSI)
  • PHUN 53.77
  • DYAI 39.42
  • Support Level
  • PHUN $2.44
  • DYAI $1.20
  • Resistance Level
  • PHUN $2.69
  • DYAI $1.29
  • Average True Range (ATR)
  • PHUN 0.19
  • DYAI 0.07
  • MACD
  • PHUN 0.05
  • DYAI 0.00
  • Stochastic Oscillator
  • PHUN 93.33
  • DYAI 18.52

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.

About DYAI Dyadic International Inc.

Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

Share on Social Networks: